Biotechnology
FGEN
8.37
price up icon2.70%   0.22
 

Fibrogen Inc (FGEN)
full-star
loading
Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt FGEN? Forum Prognose
Schlusskurs vom Vortag:
$8.15
Offen:
$8.33
24-Stunden-Volumen:
18,559
Relative Volume:
0.60
Marktkapitalisierung:
$33.74M
Einnahmen:
$147.75M
Nettoeinkommen (Verlust:
$-284.23M
KGV:
-2.8567
EPS:
-2.93
Netto-Cashflow:
$-317.54M
1W Leistung:
-4.89%
1M Leistung:
-23.91%
6M Leistung:
+9.73%
1J Leistung:
-17.39%
1-Tages-Spanne:
Value
$8.23
$8.4499
1-Wochen-Bereich:
Value
$7.99
$8.975
52-Wochen-Spanne:
Value
$4.85
$21.94

Fibrogen Inc Stock (FGEN) Company Profile

Name
Firmenname
Fibrogen Inc
Name
Sektor
Healthcare (1138)
Name
Branche
Biotechnology (632)
Name
Telefon
415-978-1200
Name
Adresse
350 BAY STREET, SAN FRANCISCO, CA
Name
Mitarbeiter
225
Name
Twitter
@FibroGenInc
Name
Nächster Verdiensttermin
2025-03-17
Name
Neueste SEC-Einreichungen
Name
FGEN's Discussions on Twitter

Vergleichen Sie FGEN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
FGEN
Fibrogen Inc
 8.34 33.37M 147.75M -284.23M -317.54M -2.93
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 455.68 116.04B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 722.69 75.97B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 458.86 61.48B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
 899.98 56.40B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
 204.78 43.73B 447.02M -1.18B -906.14M -6.1812

Fibrogen Inc Stock (FGEN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-08-08 Herabstufung BofA Securities Neutral → Underperform
2023-06-26 Herabstufung BofA Securities Buy → Neutral
2023-06-26 Herabstufung Raymond James Outperform → Mkt Perform
2023-06-26 Herabstufung Stifel Buy → Hold
2023-06-26 Herabstufung William Blair Outperform → Mkt Perform
2023-06-02 Hochstufung Stifel Hold → Buy
2023-01-31 Hochstufung William Blair Mkt Perform → Outperform
2023-01-26 Hochstufung Raymond James Mkt Perform → Outperform
2023-01-05 Hochstufung BofA Securities Neutral → Buy
2021-09-22 Herabstufung Goldman Neutral → Sell
2021-08-20 Hochstufung Raymond James Underperform → Mkt Perform
2021-07-16 Herabstufung BofA Securities Buy → Neutral
2021-07-16 Herabstufung Stifel Buy → Hold
2021-04-07 Herabstufung H.C. Wainwright Buy → Neutral
2021-04-07 Herabstufung Mizuho Buy → Neutral
2021-03-31 Hochstufung BofA Securities Neutral → Buy
2021-03-02 Herabstufung Jefferies Buy → Hold
2021-02-01 Eingeleitet H.C. Wainwright Buy
2020-10-26 Eingeleitet Raymond James Underperform
2020-07-10 Fortgesetzt Stifel Buy
2020-05-01 Eingeleitet Cowen Market Perform
2020-04-27 Eingeleitet BofA/Merrill Neutral
2019-05-29 Fortgesetzt Goldman Neutral
2019-05-10 Herabstufung William Blair Outperform → Mkt Perform
2019-04-12 Eingeleitet Piper Jaffray Neutral
2019-02-11 Fortgesetzt Stifel Buy
2018-12-19 Hochstufung Citigroup Neutral → Buy
2017-08-08 Bestätigt Leerink Partners Outperform
2017-08-08 Bestätigt Stifel Buy
2017-07-21 Herabstufung Goldman Buy → Neutral
2017-07-11 Eingeleitet Jefferies Buy
2016-02-11 Hochstufung Credit Suisse Neutral → Outperform
2016-01-21 Eingeleitet Credit Suisse Neutral
2015-12-04 Eingeleitet Citigroup Buy
2015-09-23 Eingeleitet Lake Street Hold
2015-07-29 Eingeleitet Citigroup Buy
2015-07-20 Hochstufung Goldman Neutral → Buy
2014-12-09 Eingeleitet Stifel Buy
Alle ansehen

Fibrogen Inc Aktie (FGEN) Neueste Nachrichten

pulisher
03:39 AM

Can FibroGen Inc. (1FG0) stock deliver strong annual returnsSell Signal & AI Powered Market Entry Strategies - Newser

03:39 AM
pulisher
Dec 04, 2025

Will FibroGen Inc. (1FG0) stock outperform global peers2025 Valuation Update & Safe Capital Growth Stock Tips - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Is FibroGen Inc. (1FG0) stock overpriced at current multiplesDividend Hike & Weekly Momentum Picks - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

How FibroGen Inc. (1FG0) stock reacts to fiscal policiesWeekly Trade Review & Weekly Watchlist for Hot Stocks - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

How dovish Fed policy supports FibroGen Inc. (1FG0) stockAnalyst Downgrade & Entry and Exit Point Strategies - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

How supply shortages influence FibroGen Inc. (1FG0) stockSell Signal & Weekly Return Optimization Alerts - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Is FibroGen Inc. (1FG0) stock a top hedge fund pick2025 Fundamental Recap & Smart Allocation Stock Tips - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

FibroGen, Inc. to Present at Oppenheimer Movers in Rare Disease Summit on December 11, 2025 - Quiver Quantitative

Dec 02, 2025
pulisher
Dec 02, 2025

FibroGen to Present at the Oppenheimer Movers in Rare Disease Summit - GlobeNewswire

Dec 02, 2025
pulisher
Nov 29, 2025

Will FibroGen Inc. stock outperform international peers2025 Fundamental Recap & AI Powered Buy and Sell Recommendations - BỘ NỘI VỤ

Nov 29, 2025
pulisher
Nov 27, 2025

Why FibroGen Inc. (1FG0) stock is trending on social mediaJuly 2025 PreEarnings & AI Enhanced Execution Alerts - moha.gov.vn

Nov 27, 2025
pulisher
Nov 24, 2025

FibroGen started at buy by H.C. Wainwright - MSN

Nov 24, 2025
pulisher
Nov 21, 2025

What valuation multiples suggest for FibroGen Inc. stockWeekly Trade Analysis & Verified Momentum Watchlists - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Can FibroGen Inc. (1FG0) stock ride next bull market cycle2025 Pullback Review & Short-Term Trading Opportunity Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Why FibroGen Inc. stock remains resilientPortfolio Return Summary & Real-Time Buy Signal Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Can FibroGen Inc. (1FG0) stock deliver consistent EPS growthJuly 2025 Decliners & Weekly Top Gainers Alerts - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Is FibroGen Inc. stock vulnerable to regulatory risks2025 Bull vs Bear & AI Powered Buy and Sell Recommendations - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Can FibroGen Inc. (1FG0) stock resist broad market declines2025 Volatility Report & Intraday High Probability Alerts - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Will earnings trigger a reversal in FibroGen Inc.Trade Volume Summary & Reliable Volume Spike Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What drives FibroGen Inc stock priceCandlestick Trading Patterns & Free Take Advantage Of Momentum - earlytimes.in

Nov 19, 2025
pulisher
Nov 19, 2025

Chart based exit strategy for FibroGen Inc.July 2025 Summary & Daily Technical Forecast Reports - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

What hedge fund activity signals for FibroGen Inc. stockWeekly Trading Summary & Daily Growth Stock Investment Tips - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Fibrogen CEO Wettig Thane buys shares worth $33,749 By Investing.com - Investing.com Australia

Nov 18, 2025

Finanzdaten der Fibrogen Inc-Aktie (FGEN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Fibrogen Inc-Aktie (FGEN) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Wettig Thane
CEO
Nov 13 '25
Buy
9.18
1,000
9,180
22,239
Schoeneck James A
Director
Jun 30 '25
Buy
5.07
23,567
119,485
39,666
Wettig Thane
CEO
Mar 24 '25
Buy
0.35
145,000
50,663
543,329
Schoeneck James A
Director
Mar 20 '25
Buy
0.35
250,000
88,000
323,722
Schoeneck James A
Director
Mar 21 '25
Buy
0.34
50,000
17,040
373,722

Ähnlich wie FGEN

biotechnology RPRX
$39.43
price up icon 0.79%
biotechnology GMAB
$31.73
price down icon 0.96%
biotechnology INCY
$103.04
price up icon 2.54%
biotechnology BNTX
$96.30
price up icon 0.27%
biotechnology ONC
$319.25
price down icon 3.72%
biotechnology INSM
$204.76
price down icon 0.18%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters
Kapitalisierung:     |  Volumen (24h):